(DIAGNOSTIC IMAGING @ RSNA 2009) -- Rather than retreating after the hard blow handed them by the Centers for Medicare and Medicaid Services, which refused to grant reimbursement for the application in May, CT colonography researchers will arrive at the 2009 RSNA meeting with more of what CMS wants: hard data. CMS' decision intensified the debate on CTC's worth for colorectal cancer screening and whether it should be accepted in routine practice. When it came to CTC's alleged weaknesses, the government cited a lack of conclusive data on benefits and harms to back its policy. Since then, however, the evidence that CTC is a screening procedure just as good as or better than colonoscopy has continued to pile up, said Dr. Benjamin M. Yeh, chair of the RSNA's scientific gastrointestinal radiology subcommittee.
See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC